Free Trial

15 Healthcare Stocks that Analysts Love in a Post-Pandemic World - 9 of 15

 
 

HCA Healthcare (NYSE:HCA)

Consensus Rating
Moderate Buy
Rating Score
2.8
Ratings Breakdown
14 Buy Ratings, 5 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$385.00 (12.3% Upside)

About HCA Healthcare

HCA Healthcare logoHCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
11/8/2024BarclaysLower Price TargetOverweight ➝ Overweight$396.00 ➝ $392.00
11/6/2024Wells Fargo & CompanyBoost Price TargetEqual Weight ➝ Equal Weight$395.00 ➝ $400.00
10/28/2024TD CowenLower Price TargetBuy ➝ Buy$450.00 ➝ $440.00
10/28/2024OppenheimerBoost Price TargetOutperform ➝ Outperform$390.00 ➝ $400.00
10/28/2024KeyCorpLower Price TargetOverweight ➝ Overweight$475.00 ➝ $420.00
10/22/2024Wells Fargo & CompanyBoost Price TargetEqual Weight ➝ Equal Weight$365.00 ➝ $395.00
10/11/2024KeyCorpInitiated CoverageOverweight$475.00
10/10/2024KeyCorpUpgradeStrong-Buy
10/1/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$392.00 ➝ $392.00
9/3/2024Morgan StanleyInitiated CoverageEqual Weight$427.00
 

There is a little known company that is changing warfare (Ad)

With geo - political instability around the world investors are flocking to defense contract stocks. There is a little known company that is changing warfare. With the backing of U.S. government contracts, this startup is reshaping the future of the U.S. military.

Click here to gain instant access to one of the most exclusive pre-ipo opportunities in the market t